Faculty, fellows, staff and students in the Division of Clinical Pharmacology at IU School of Medicine regularly contribute to the research and study of clinical pharmacology as well as the education of future practitioners through engaging local events.
News and upcoming events in the Division of Clinical Pharmacology are posted as they become available.
Omar Aboshady, MD, MSc, has been selected to present in an Oral Poster Session titled, Changes In QTC Across Different Trimesters of Pregnancy and Pre-Eclampsia: A Systematic Review and Meta-Analysis.
Surya Bhamidipaty-Pelosi, MD, MS, DRANZCOG’s abstract, Characterization of Labetalol in Pregnancy (the CLIP Study) has been accepted as a Trials in Progress abstract.
Aislinn O’Kane, PharmD’s abstract, Physiologically Based Pharmacokinetic Model to Assess the Impact of Genetic Variability in Patients Receiving Dexmedetomidine has been accepted for presentation at the ASCPT 2024 Annual Meeting.
Gerald So, PharmD’s abstract, Inhibition of Tacrolimus Metabolism by Cannabidiol and Its Metabolites In Vitro, has been accepted for presentation and will be receiving a Presidential Trainee Award at the ASCPT 2024 Annual Meeting. In recognition of this high-quality abstract, Gerald has also been chosen as a recipient of a Top Poster Ribbon.
Gerald So, PharmD’s Trials in Progress abstract, Drug-Gene-Nutraceutical Interactions of Cannabidiol and Tacrolimus has been accepted for presentation at the ASCPT Annual meeting.
Min Yue, BS’s abstract, Oral Progesterone-Mediated Attenuation of Ibutilide-Induced QT Interval Lengthening in Premenopausal and Postmenopausal Women: Population Pharmacokinetic/Pharmacodynamic Model has been accepted for presentation and will be receiving a Presidential Trainee Award at the ASCPT 2024 Annual Meeting. In recognition of this high-quality abstract, Min has also been chosen as a recipient of a Top Poster Ribbon.
Syed Zaidi, PharmD, PhD has been selected to present, DEVELOPMENT AND VERIFICATION OF A NIFEDIPINE CONTROLLED RELEASE PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL IN PREGNANCY, and will be receiving a Presidential Trainee Award. In recognition of this high-quality abstract, Syed has also been chosen as a recipient of a Top Poster Ribbon.
Meena S. Madhur, MD, PhD, has been named the new Director the Division of Clinical Pharmacology in the Department of Medicine at Indiana University School of Medicine. She will begin this role August 15, 2023.
The second largest federally funded research program at Indiana University School of Medicine will receive $48.8 million over the next five years, fueling the work of researchers as they seek to discover treatments for Alzheimer’s disease.
On Monday, September 26, IU School of Medicine announced the 2022 recipients of the Showalter Scholar award.
In 2020, a partnership between Indiana University School of Medicine and Eli Lilly and Company was created to collaborate in specific areas of scientific development. Leaders of this effort say the progress so far from the five year, $5 million collaboration is a good sign for potential expansion in the future.
